Gitterman Wealth Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,578
Closed -$217K 156
2024
Q4
$217K Buy
+8,578
New +$217K 0.09% 104
2024
Q3
Sell
-7,984
Closed -$237K 145
2024
Q2
$237K Buy
7,984
+1,197
+18% +$33.2K 0.09% 83
2024
Q1
$205K Buy
+6,787
New +$188K 0.08% 93
2023
Q4
Sell
-5,974
Closed -$221K 105
2023
Q3
$221K Buy
5,974
+443
+8% +$16.9K 0.11% 60
2023
Q2
$216K Buy
+5,531
New +$217K 0.1% 70

Other funds holding RTO

Gitterman Wealth Management's RTO Position: Q1 2025 in Review

Gitterman Wealth Management sold out of Rentokil (RTO) in Q1 2025, closing a stake of 8,578 shares — an estimated $217K sold.

Gitterman Wealth Management first reported a position in RTO in Q2 2023 and held it in 5 quarters. The position peaked at $237K in Q2 2024. 209 funds tracked by Wall St. Rank hold RTO as of Q1 2025.

  • Gitterman Wealth Management reported no remaining Rentokil position as of Q1 2025 after selling out during the quarter.
  • Gitterman Wealth Management sold 8,578 Rentokil shares in Q1 2025, an estimated $217K.
  • Gitterman Wealth Management first reported a position in Rentokil in Q2 2023 and held it in 5 quarters.
  • Gitterman Wealth Management's Rentokil position peaked at $237K in Q2 2024.
  • 209 funds tracked by Wall St. Rank held Rentokil as of Q1 2025.

Based on Gitterman Wealth Management's 13F filing for Q1 2025, filed 14 May 2025.